Subsequent Events (Details) - Forecast [Member] $ / shares in Units, $ in Thousands |
1 Months Ended | ||
---|---|---|---|
Mar. 31, 2023
shares
|
Feb. 27, 2023
USD ($)
shares
|
Feb. 22, 2023
USD ($)
$ / shares
shares
|
|
Subsequent Events (Details) [Line Items] | |||
Options granted to employees | 1,567,000 | ||
Number of employees | 50 | ||
Exercise price, per share | 0.4 | ||
Vesting period | 4 years | ||
Aggregate shares | 5,975,918 | 30,608,163 | |
Price per share (in Dollars per share) | $ / shares | $ 0.245 | ||
Warrant price per share (in Dollars per share) | $ / shares | $ 0.244 | ||
Aggregate net proceeds (in Dollars) | $ | $ 1,461 | $ 7,484 |
X | ||||||||||
- Definition Aggregate net proceeds . No definition available.
|
X | ||||||||||
- Definition Exercise price of options granted. No definition available.
|
X | ||||||||||
- Definition Number of employees approved options granted. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|